Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NEOADJUVANT CHEMOTHERAPY, . Treffer: 49

2023

Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1): Doi: 10.3390/ijms24010818 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Schwering, C; Niethard, M; Gosheger, G; Smolle, MA; Traub, F; Adam, S; Henrichs, MP; Dürr, HR; Hardes, J; Tunn, PU; Leithner, A; Andreou, D Are Postoperative Infections in the First 12 Months after Wide Resection and Megaprosthetic Replacement Associated with the Survival of Osteosarcoma Patients? Results of a Multicenter Study.
Cancers (Basel). 2022; 14(11): 2682 Doi: 10.3390/cancers14112682 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Banys-Paluchowski, M; Gasparri, ML; de, Boniface, J; Gentilini, O; Stickeler, E; Hartmann, S; Thill, M; Rubio, IT; Di, Micco, R; Bonci, EA; Niinikoski, L; Kontos, M; Karadeniz, Cakmak, G; Hauptmann, M; Peintinger, F; Pinto, D; Matrai, Z; Murawa, D; Kadayaprath, G; Dostalek, L; Nina, H; Krivorotko, P; Classe, JM; Schlichting, E; Appelgren, M; Paluchowski, P; Solbach, C; Blohmer, JU; Kühn, T; The, Axsana, Study, Group Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.
Cancers (Basel). 2021; 13(7): Doi: 10.3390/cancers13071565 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Birrer, DL; Golcher, H; Casadei, R; Haile, SR; Fritsch, R; Hussung, S; Brunner, TB; Fietkau, R; Meyer, T; Grützmann, R; Merkel, S; Ricci, C; Ingaldi, C; Di, Marco, M; Guido, A; Serra, C; Minni, F; Pestalozzi, B; Petrowsky, H; DeOliveira, M; Bechstein, WO; Bruns, CJ; Oberkofler, CE; Puhan, M; Lesurtel, M; Heinrich, S; Clavien, PA Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.
Ann Surg. 2021; 274(5): 713-720. Doi: 10.1097/SLA.0000000000005126
Web of Science PubMed FullText FullText_MUG

 

Pieper, W; Ignatov, A; Kalinski, T; Haybaeck, J; Czapiewski, P; Nass, N The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer.
Cancer Biomark. 2021; 32(2):161-173 Doi: 10.3233/CBM-203127
Web of Science PubMed FullText FullText_MUG

 

Reitsamer, R; Peintinger, F; Forsthuber, E; Sir, A The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy.
Breast. 2021; 57:113-117 Doi: 10.1016/j.breast.2021.03.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10): Doi: 10.3390/cancers13102492 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Ackmann, T; Klingebiel, S; Gosheger, G; Rachbauer, A; Theil, C; Andreou, D Reconstruction of Total Bone Defects following Resection of Malignant Tumors of the Upper Extremity with 3D Printed Prostheses: Presentation of Two Patients with a Follow-Up of Three Years.
Case Rep Orthop. 2020; 2020:8822466 Doi: 10.1155/2020/8822466 (- Case Report) [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Andreou, D; Ranft, A; Gosheger, G; Timmermann, B; Ladenstein, R; Hartmann, W; Bauer, S; Baumhoer, D; van den Berg, H; Dijkstra, PDS; Dürr, HR; Gelderblom, H; Hardes, J; Hjorth, L; Kreyer, J; Kruseova, J; Leithner, A; Scobioala, S; Streitbürger, A; Tunn, PU; Wardelmann, E; Windhager, R; Jürgens, H; Dirksen, U; GPOH-Euro-EWING99 consortium Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Clin Orthop Relat Res. 2020; 478(2):290-302 Doi: 10.1097/CORR.0000000000000962 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Distler, FA; Pahernik, S; Gakis, G; Hutterer, G; Lebentrau, S; Rink, M; Nuhn, P; Brookman-May, S; Burger, M; Gratzke, C; Wolff, I; May, M Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
World J Urol. 2020; 38(10):2523-2530 Doi: 10.1007/s00345-019-03052-7
Web of Science PubMed FullText FullText_MUG

 

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106 Doi: 10.1016/j.ejca.2020.04.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Roessner, A; Schoeder, V; Smolle, M; Haybäck, J [Osteoid-forming bone tumors : Morphology and current translational cell biology].
Pathologe. 2020; 41(2):123-133 Doi: 10.1007/s00292-020-00763-2
Web of Science PubMed FullText FullText_MUG

 

Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1): Doi: 10.3390/cancers12010047 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Fabian, E; Eherer, AJ; Lackner, C; Urban, C; Smolle-Juettner, FM; Krejs, GJ Pseudoachalasia as First Manifestation of a Malignancy.
Dig Dis. 2019; 37(5):347-354 Doi: 10.1159/000495758 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hutterer, GC Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics.
Int J Mol Sci. 2019; 20(15): 3790 Doi: 10.3390/ijms20153790 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Vujic, J; Schöllnast, H; Marsoner, K; Wienerroither, V; Bacher, H; Mischinger, HJ; Kornprat, P Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
Anticancer Res. 2019; 39(7):3847-3854 Doi: 10.21873/anticanres.13534 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Kühn, T; Classe, JM; Gentilini, OD; Tinterri, C; Peintinger, F; de Boniface, J Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting.
Breast Care (Basel). 2018; 13(5):337-341 Doi: 10.1159/000492437 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

O'Loughlin, M; Andreu, X; Bianchi, S; Chemielik, E; Cordoba, A; Cserni, G; Figueiredo, P; Floris, G; Foschini, MP; Heikkilä, P; Kulka, J; Liepniece-Karele, I; Regitnig, P; Reiner, A; Ryska, A; Sapino, A; Shalaby, A; Stovgaard, ES; Quinn, C; Walsh, EM; Zolota, V; Glynn, SA; Callagy, G Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
BREAST CANCER RES TR. 2018; 171(1): 1-9. Doi: 10.1007/s10549-018-4825-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 Doi: 10.1016/j.ejca.2016.12.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Ignatiadis, M; Rack, B; Rothé, F; Riethdorf, S; Decraene, C; Bonnefoi, H; Dittrich, C; Messina, C; Beauvois, M; Trapp, E; Goulioti, T; Tryfonidis, K; Pantel, K; Repollet, M; Janni, W; Piccart, M; Sotiriou, C; Litiere, S; Pierga, JY Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.
Eur J Cancer. 2016; 63(10):97-104 Doi: 10.1016/j.ejca.2016.04.024
Web of Science PubMed FullText FullText_MUG

 

2015

Gakis, G; Morgan, TM; Daneshmand, S; Keegan, KA; Todenhöfer, T; Mischinger, J; Schubert, T; Zaid, HB; Hrbacek, J; Ali-El-Dein, B; Clayman, RH; Galland, S; Olugbade, K; Rink, M; Fritsche, HM; Burger, M; Chang, SS; Babjuk, M; Thalmann, GN; Stenzl, A; Efstathiou, JA Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Ann Oncol. 2015; 26(8):1754-1759 Doi: 10.1093/annonc/mdv230 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 Doi: 10.1371/journal.pone.0125364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kremer, M; Manzini, G; Hristov, B; Polychronidis, G; Mokry, T; Sommer, CM; Mehrabi, A; Weitz, J; Büchler, MW; Schemmer, P Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
J Am Coll Surg. 2015; 221(3):717-728 Doi: 10.1016/j.jamcollsurg.2015.05.017
Web of Science PubMed FullText FullText_MUG

 

2013

Basharkhah, A; Pansy, J; Urban, C; Höllwarth, ME Outcomes after interdisciplinary management of 7 patients with Askin tumor.
Pediatr Surg Int. 2013; 29(5):431-436 Doi: 10.1007/s00383-013-3272-1
Web of Science PubMed FullText FullText_MUG

 

2012

Shariat, SF; Ehdaie, B; Rink, M; Cha, EK; Svatek, RS; Chromecki, TF; Fajkovic, H; Novara, G; David, SG; Daneshmand, S; Fradet, Y; Lotan, Y; Sagalowsky, AI; Clozel, T; Bastian, PJ; Kassouf, W; Fritsche, HM; Burger, M; Izawa, JI; Tilki, D; Abdollah, F; Chun, FK; Sonpavde, G; Karakiewicz, PI; Scherr, DS; Gonen, M Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur Urol. 2012; 61(2): 237-242. Doi: 10.1016/j.eururo.2011.10.011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764 Doi: 10.1007/s00438-012-0715-7
Web of Science PubMed FullText FullText_MUG

 

2011

Andreou, D; Bielack, SS; Carrle, D; Kevric, M; Kotz, R; Winkelmann, W; Jundt, G; Werner, M; Fehlberg, S; Kager, L; Kühne, T; Lang, S; Dominkus, M; Exner, GU; Hardes, J; Hillmann, A; Ewerbeck, V; Heise, U; Reichardt, P; Tunn, PU The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Ann Oncol. 2011; 22(5): 1228-1235. Doi: 10.1093/annonc/mdq589
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641 Doi: 10.1016/S1470-2045(11)70122-X
Web of Science PubMed FullText FullText_MUG

 

Mikalauskas, S; Mikalauskiene, L; Bruns, H; Nickkholgh, A; Hoffmann, K; Longerich, T; Strupas, K; Büchler, MW; Schemmer, P Dietary glycine protects from chemotherapy-induced hepatotoxicity.
Amino Acids. 2011; 40(4):1139-1150 Doi: 10.1007/s00726-010-0737-6
Web of Science PubMed FullText FullText_MUG

 

2010

Sardanelli, F; Boetes, C; Borisch, B; Decker, T; Federico, M; Gilbert, FJ; Helbich, T; Heywang-Kobrunner, SH; Kaiser, WA; Kerin, MJ; Mansel, RE; Marotti, L; Martincich, L; Mauriac, L; Meijers-Heijboer, H; Orecchia, R; Panizza, P; Ponti, A; Purushotham, AD; Regitnig, P; Del Turco, MR; Thibault, F; Wilson, R Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
EUR J CANCER. 2010; 46(8): 1296-1316. Doi: 10.1016/j.ejca.2010.02.015
Web of Science PubMed FullText FullText_MUG

 

2007

Bader, AA; Petru, E; Winter, R Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy.
Gynecol Oncol. 2007; 105(1):269-272 Doi: 10.1016/j.ygyno.2007.01.009 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kornprat, P; Jarnagin, WR; Gonen, M; DeMatteo, RP; Fong, Y; Blumgart, LH; D'Angelica, M Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
Ann Surg Oncol. 2007; 14(3):1151-1160 Doi: 10.1245/s10434-006-9068-y
Web of Science PubMed FullText FullText_MUG

 

Steger, GG; Galid, A; Gnant, M; Mlineritsch, B; Lang, A; Tausch, C; Rudas, M; Greil, R; Wenzel, C; Singer, CF; Haid, A; Postlberger, S; Samonigg, H; Luschin-Ebengreuth, G; Kwasny, W; Klug, E; Kubista, E; Menzel, C; Jakesz, R Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
J Clin Oncol. 2007; 25(15):2012-2018 Doi: 10.1200/JCO.2006.09.1777 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Bader, AA; Winter, R; Moinfar, F; Petru, E; Pristauz, G; Scholz, HS; Haas, J; Tamussino, KF Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?
Gynecol Oncol. 2006; 103(1):106-112 Doi: 10.1016/j.ygyno.2006.01.051
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Peintinger, F; Kuerer, HM; Anderson, K; Boughey, JC; Meric-Bernstam, F; Singletary, SE; Hunt, KK; Whitman, GJ; Stephens, T; Buzdar, AU; Green, MC; Symmans, WF Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Ann Surg Oncol. 2006; 13(11): 1443-1449. Doi: 10.1245/s10434-006-9086-9
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Symmans, WF; Gonzalez-Angulo, AM; Boughey, JC; Buzdar, AU; Yu, TK; Hunt, KK; Singletary, SE; Babiera, GV; Lucci, A; Meric-Bernstam, F; Kuerer, HM The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Cancer. 2006; 107(6): 1248-1254. Doi: 10.1002/cncr.22111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sovinz, P; Urban, C; Lackner, H; Benesch, M; Langmann, G Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Wien Klin Wochenschr. 2006; 118(1-2):22-30 Doi: 10.1007/s00508-005-0503-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Lehner, M; Stehr, M; Till, H; Schuster, T; Dietz, HG Functional imaging for determination of nephroblastoma: An obligatory diagnostic program
EUR J PEDIATR SURG. 2005; 15(5): 343-346. Doi: 10.1055/s-2005-837606 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Reitsamer, R; Peintinger, F; Prokop, E; Hitzl, W Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
Anticancer Drugs. 2005; 16(8): 867-870. Doi: 10.1097/01.cad.0000173475.59616.b4
Web of Science PubMed FullText FullText_MUG

 

2003

Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
J Surg Oncol. 2003; 84(2):63-67 Doi: 10.1002/jso.10294
Web of Science PubMed FullText FullText_MUG

 

2001

Sluga, M; Windhager, R; Lang, S; Heinzl, H; Krepler, P; Mittermayer, F; Dominkus, M; Zoubek, A; Kotz, R The role of surgery and resection margins in the treatment of Ewing's sarcoma.
Clin Orthop Relat Res. 2001; 123(392):394-399 Doi: 10.1097%2F00003086-200111000-00051
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Thurnher, D; Kletzmayr, J; Formanek, M; Quint, C; Czerny, C; Burian, M; Kornek, G Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Oncology. 2001; 61(2):143-146 Doi: 10.1159/000055365 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2000

Kortmann, RD; Kühl, J; Timmermann, B; Mittler, U; Urban, C; Budach, V; Richter, E; Willich, N; Flentje, M; Berthold, F; Slavc, I; Wolff, J; Meisner, C; Wiestler, O; Sörensen, N; Warmuth-Metz, M; Bamberg, M Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
INT J RADIAT ONCOL BIOL PHYS. 2000; 46(2): 269-279. Doi: 10.1016/S0360-3016(99)00369-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Trieb, K; Lechleitner, T; Lang, S; Windhager, R; Kotz, R; Dirnhofer, S Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Pathol Res Pract. 1998; 194(10):679-684 Doi: 10.1016/S0344-0338(98)80126-X
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Trieb, K; Lechleitner, T; Lang, S; Windhager, R; Kotz, R; Dirnhofer, S Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy.
Hum Pathol. 1998; 29(10):1050-1055 Doi: 10.1016/S0046-8177(98)90412-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Cerwenka, H; Hoff, M; Rosanelli, G; Hauser, H; Thalhammer, M; Smola, MG; Klimpfinger, M Experience with a high speed biopsy gun in breast cancer diagnosis.
Eur J Surg Oncol. 1997; 23(3):206-207 Doi: 10.1016/S0748-7983(97)92268-X
Web of Science PubMed FullText FullText_MUG

 

1996

Hartmann, JT; Thiel, I; Schmoll, HJ; Einsele, H; Kanz, L; Bokemeyer, C Malignant Fibrous Histiocytoma of Bone - Review of 13 Cases
ONCOL REP 1996 3: 813-817. Doi: 10.3892/or.3.5.813
Web of Science FullText FullText_MUG

 

1993

Stauber, RE; Mischinger, HJ; Trauner, M; Pristautz, H Indications for liver transplantation in neoplasms of the liver.
Acta Med Austriaca. 1993; 20(3):57-60
Web of Science PubMed Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum